Skip to main content

Day One Biopharmaceuticals, Inc.

DAWNDelisted Apr 23, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001845337

Day One Biopharmaceuticals, Inc. was delisted on Apr 23, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 208 institutions reported holding it in 13F filings for Q1 2026, worth $1.85B in total; Soros Fund Management was the only superinvestor holding it.

Q2 2022 vs. Q1 2022

How the institutions holding Day One Biopharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of DAWN: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders66287+23
Shares43.3M18.1K59.4M+16.1M (+37.2%)
Value$429.6M$179.0K$1.06B+$632.7M (+147.4%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (34)

Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to DAWN in Q2 2022
InstitutionSharesValue% of portfolio
Polar Capital Holdings Plc971,696$17.4M0.13%
Commodore Capital LP739,661$13.2M2.80%
Woodline Partners LP150,176$2.69M0.04%
D. E. Shaw & Co., Inc.138,318$2.48M0.00%
Simplex Trading, LLC132,926$2.38M0.08%
Renaissance Technologies LLC116,630$2.09M0.00%
Parkman Healthcare Partners LLC114,750$2.05M0.76%
Macquarie Group Ltd110,000$1.97M0.00%
Silverarc Capital Management, LLC105,476$1.89M0.88%
Invesco Ltd.97,024$1.74M0.00%
Maven Securities LTD80,000$1.43M0.25%
Cubist Systematic Strategies, LLC61,237$1.10M0.01%
Ergoteles LLC56,300$1.01M0.03%
Allianz Asset Management GmbH51,325$919.0K0.00%
Alliancebernstein L.P.42,400$759.0K0.00%
Schonfeld Strategic Advisors LLC40,300$722.0K0.01%
HRT Financial LP35,426$634.0K0.01%
Monashee Investment Management LLC30,000$537.0K0.20%
Occudo Quantitative Strategies LP23,619$423.0K0.03%
ExodusPoint Capital Management, LP23,003$412.0K0.01%
State Board of Administration of Florida Retirement System13,760$246.0K0.00%
SG Americas Securities, LLC9,446$169.0K0.00%
UBS Group AG3,851$69.0K0.00%
Quantbot Technologies LP2,900$51.0K0.00%
TCI Wealth Advisors, Inc.1,974$35.0K0.01%
FourThought Financial, LLC1,850$33.0K0.00%
ACG Wealth1,772$32.0K0.01%
Quintet Private Bank (Europe) S.A.2,302$27.5K0.00%
Washington Trust Advisors, Inc.163$3.00K0.00%
Crewe Advisors LLC80$1.00K0.00%
Credit Suisse AG23$00.00%
CWM, LLC3$00.00%
Ellevest, Inc.10$00.00%
Advisor Group Holdings, Inc.1$00.00%

Sold out (11)

Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of DAWN in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Janus Henderson Group PLC902,020$8.95M
BVF Inc809,282$8.03M
Two Sigma Investments, LP60,190$597.0K
Walleye Capital LLC26,148$259.0K
State of Tennessee, Treasury Department25,460$253.0K
Two Sigma Advisers, LP19,900$197.0K
Susquehanna International Group, LLP18,604$185.0K
Nan Fung Group Holdings Ltd11,445$114.0K
ProShare Advisors LLC10,675$106.0K
The PNC Financial Services Group, Inc.175$2.00K
Private Capital Group, LLC142$1.00K

Not filed for Q2 2022 yet (2)

Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DAWN in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC15,016$149.0K
Amalgamated Financial Corp.3,034$30.0K